Peptide
SEMAX 30MG
Semax is a synthetic heptapeptide analogue of the ACTH(4-7) fragment developed for neuroscience research applications. This 30mg formulation is designed for laboratory investigation into BDNF pathway modulation, neuroprotection mechanisms, and cognitive neuroscience research.
Semax has been extensively studied in preclinical neuroscience research for its proposed role in upregulating brain-derived neurotrophic factor (BDNF) and its influence on serotonergic, dopaminergic, and cholinergic neurotransmitter systems.
Research Applications
- BDNF and NGF expression upregulation studies in neuronal cell lines
- Neuroprotection against ischemic and excitotoxic injury models
- Dopaminergic and serotonergic pathway modulation research
- Cognitive function and memory consolidation pathway studies
- Neuroinflammation and glial cell activity investigations
Key Features
- Synthetic ACTH(4-7) analogue — 30mg research vial
- Studied for BDNF pathway modulation and neuroprotection research
- Research-grade purity, independently verified
- For laboratory and investigational use only
Research application details for SEMAX 30MG. For specific protocol information, please refer to current peer-reviewed literature.
- Research-grade purity, independently verified
- Certificate of Analysis included with every order
- SEMAX 30MG — Default Title
- Intended strictly for laboratory and research use only
This product is intended for laboratory research purposes only. This product is not approved by the FDA for human consumption, diagnosis, treatment, cure, or prevention of any disease. Not for medical or veterinary use.